HomeClinical TopicsFDA approves new treatment for bladder cancer

FDA approves new treatment for bladder cancer

On May 18, the U.S. the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) to treat urothelial carcinoma. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content